| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |